LUNG DIFFUSION CAPACITY AND NON-SPECIFIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS

Aim. To assess the differences in the lung diffusion capacity and non-specific inflammation markers among patients with coronary heart disease (CHD) and the combination of CHD and Type 2 diabetes mellitus (DM-2). Material and methods. The study included 70 CHD patients: with DM-2 (n=40; 57,1%) and w...

Full description

Bibliographic Details
Main Authors: E. D. Bazdyrev, Yu. V. Bayrakova, O. M. Polikutina, N. A. Bezdenezhnykh, Yu S. Slepynina, O. L. Barbarash
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2013-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/434
Description
Summary:Aim. To assess the differences in the lung diffusion capacity and non-specific inflammation markers among patients with coronary heart disease (CHD) and the combination of CHD and Type 2 diabetes mellitus (DM-2). Material and methods. The study included 70 CHD patients: with DM-2 (n=40; 57,1%) and without DM-2 (n=30; 42,9%). Lung diffusion capacity (DIco) was assessed with the single-breath method and subsequent correction by haemoglobin levels (DIco cor). The levels of the following non-specific inflammation markers were also assessed: IL-1
ISSN:1560-4071
2618-7620